NASDAQ:CBIO | Insider Transactions — Page 3 | CRESCENT BIOPHARMA, INC.

CBIO Insider Transactions — Page 3

296 retained open-market purchase and sale rows from SEC Forms 3, 4 and 5, newest first. This page shows rows 201–296; provenance stays internal.

Insider profileRoleDateTransactionSharesPrice
BVF INC/ILTenPercentOwner2020-10-30Purchase250,755.0$2.75
BIOTECHNOLOGY VALUE FUND II LPOther2020-10-30Purchase250,755.0$2.75
LAMPERT MARK NTenPercentOwner2020-10-30Purchase250,755.0$2.75
Biotechnology Value Trading Fund OS LPOther2020-10-30Purchase250,755.0$2.75
BVF Partners OS Ltd.Other2020-10-30Purchase250,755.0$2.75
BVF I GP LLCOther2020-10-30Purchase250,755.0$2.75
BVF II GP LLCOther2020-10-30Purchase250,755.0$2.75
BVF GP HOLDINGS LLCTenPercentOwner2020-10-30Purchase250,755.0$2.75
BIOTECHNOLOGY VALUE FUND L POther2020-10-30Purchase666,385.0$2.75
BVF PARTNERS L P/ILTenPercentOwner2020-10-30Purchase666,385.0$2.75
BVF INC/ILTenPercentOwner2020-10-30Purchase666,385.0$2.75
BIOTECHNOLOGY VALUE FUND II LPOther2020-10-30Purchase666,385.0$2.75
LAMPERT MARK NTenPercentOwner2020-10-30Purchase666,385.0$2.75
Biotechnology Value Trading Fund OS LPOther2020-10-30Purchase666,385.0$2.75
BVF Partners OS Ltd.Other2020-10-30Purchase666,385.0$2.75
BVF I GP LLCOther2020-10-30Purchase666,385.0$2.75
BVF II GP LLCOther2020-10-30Purchase666,385.0$2.75
BVF GP HOLDINGS LLCTenPercentOwner2020-10-30Purchase666,385.0$2.75
JUNIUS DANIEL MDirector2020-03-09Purchase20,000.0$3.4
BIOTECHNOLOGY VALUE FUND L POther2019-09-05Purchase124,956.0$3.18
BVF PARTNERS L P/ILTenPercentOwner2019-09-05Purchase124,956.0$3.18
BVF INC/ILTenPercentOwner2019-09-05Purchase124,956.0$3.18
BIOTECHNOLOGY VALUE FUND II LPOther2019-09-05Purchase124,956.0$3.18
LAMPERT MARK NTenPercentOwner2019-09-05Purchase124,956.0$3.18
Biotechnology Value Trading Fund OS LPOther2019-09-05Purchase124,956.0$3.18
BVF Partners OS Ltd.Other2019-09-05Purchase124,956.0$3.18
BIOTECHNOLOGY VALUE FUND L POther2019-09-05Purchase689,834.0$3.18
BVF PARTNERS L P/ILTenPercentOwner2019-09-05Purchase689,834.0$3.18
BVF INC/ILTenPercentOwner2019-09-05Purchase689,834.0$3.18
BIOTECHNOLOGY VALUE FUND II LPOther2019-09-05Purchase689,834.0$3.18
LAMPERT MARK NTenPercentOwner2019-09-05Purchase689,834.0$3.18
Biotechnology Value Trading Fund OS LPOther2019-09-05Purchase689,834.0$3.18
BVF Partners OS Ltd.Other2019-09-05Purchase689,834.0$3.18
BIOTECHNOLOGY VALUE FUND L POther2019-09-05Purchase853,956.0$3.18
BVF PARTNERS L P/ILTenPercentOwner2019-09-05Purchase853,956.0$3.18
BVF INC/ILTenPercentOwner2019-09-05Purchase853,956.0$3.18
BIOTECHNOLOGY VALUE FUND II LPOther2019-09-05Purchase853,956.0$3.18
LAMPERT MARK NTenPercentOwner2019-09-05Purchase853,956.0$3.18
Biotechnology Value Trading Fund OS LPOther2019-09-05Purchase853,956.0$3.18
BVF Partners OS Ltd.Other2019-09-05Purchase853,956.0$3.18
JUNIUS DANIEL MDirector2019-08-13Purchase10,000.0$3.18
Magnani John L.SVP of Research, CSO2018-10-18Sale3,527.0$14.02
Magnani John L.SVP of Research, CSO2018-10-17Sale7,273.0$14.0
Magnani John L.SVP of Research, CSO2018-10-16Sale14,200.0$14.01
Hahn Brian M.CFO2018-06-11Sale19,345.0$18.04
SANDELL SCOTT DTenPercentOwner2018-05-10Sale5,533.0$17.81
SANDELL SCOTT DTenPercentOwner2018-05-10Sale4,006.0$17.81
BARRIS PETER JTenPercentOwner2018-05-10Sale5,533.0$17.81
BARRIS PETER JTenPercentOwner2018-05-10Sale4,006.0$17.81
BARRETT M JAMESDirector,TenPercentOwner2018-05-10Sale5,533.0$17.81
BARRETT M JAMESDirector,TenPercentOwner2018-05-10Sale4,006.0$17.81
NEW ENTERPRISE ASSOCIATES 10 L PTenPercentOwner2018-05-10Sale5,533.0$17.81
NEA PARTNERS 10 L PTenPercentOwner2018-05-10Sale5,533.0$17.81
NEW ENTERPRISE ASSOCIATES 10 L PTenPercentOwner2018-05-10Sale4,006.0$17.81
NEA PARTNERS 10 L PTenPercentOwner2018-05-10Sale4,006.0$17.81
Thackray Helen M.SVP Clinical Development, CMO2017-12-08Sale2,000.0$15.01
Thackray Helen M.SVP Clinical Development, CMO2017-09-18Sale2,000.0$13.0
Thackray Helen M.SVP Clinical Development, CMO2017-05-25Sale2,000.0$15.57
Thackray Helen M.SVP Clinical Development, CMO2017-05-19Sale2,000.0$12.14
JUNIUS DANIEL MDirector2016-12-20Purchase5,000.0$6.01
Thackray Helen M.VP Clinical Development, CMO2016-10-03Sale100.0$7.01
Thackray Helen M.VP Clinical Development, CMO2016-10-03Sale3,900.0$7.0
Thackray Helen M.VP Clinical Development, CMO2016-07-20Sale2,000.0$8.0
Thackray Helen M.VP Clinical Development, CMO2016-07-06Sale6,796.0$6.68
Thackray Helen M.VP Clinical Development, CMO2016-07-05Sale10,136.0$7.01
Thackray Helen M.VP Clinical Development, CMO2016-07-01Sale5,068.0$7.4
Goldberg Mark AlanDirector2016-03-04Purchase10,397.0$4.77
SANDELL SCOTT DTenPercentOwner2015-11-16Sale452.0$6.91
BARRIS PETER JTenPercentOwner2015-11-16Sale452.0$6.91
BARRETT M JAMESDirector,TenPercentOwner2015-11-16Sale452.0$6.91
NEW ENTERPRISE ASSOCIATES 10 L PTenPercentOwner2015-11-16Sale452.0$6.91
NEA PARTNERS 10 L PTenPercentOwner2015-11-16Sale452.0$6.91
HENOS MICHAEL ADirector2014-12-22Sale10,659.0$8.44
HENOS MICHAEL ADirector2014-12-19Sale10,598.0$8.61
HENOS MICHAEL ADirector2014-12-17Sale5,121.0$8.97
HENOS MICHAEL ADirector2014-12-15Sale1,604.0$8.98
HENOS MICHAEL ADirector2014-06-13Purchase5,000.0$6.21
HENOS MICHAEL ADirector2014-06-12Purchase6,000.0$6.54
BARRIS PETER JTenPercentOwner2014-01-15Purchase512,500.0$8.0
BARRIS PETER JTenPercentOwner2014-01-15Purchase487,500.0$8.0
SANDELL SCOTT DTenPercentOwner2014-01-15Purchase512,500.0$8.0
SANDELL SCOTT DTenPercentOwner2014-01-15Purchase487,500.0$8.0
BARRETT M JAMESDirector,TenPercentOwner2014-01-15Purchase512,500.0$8.0
BARRETT M JAMESDirector,TenPercentOwner2014-01-15Purchase487,500.0$8.0
MOTT DAVID MTenPercentOwner2014-01-15Purchase512,500.0$8.0
KERINS PATRICK JTenPercentOwner2014-01-15Purchase512,500.0$8.0
KOLLURI KRISHNA KITTUTenPercentOwner2014-01-15Purchase512,500.0$8.0
BASKETT FORESTTenPercentOwner2014-01-15Purchase512,500.0$8.0
DRANT RYAN DTenPercentOwner2014-01-15Purchase512,500.0$8.0
Weller Harry RTenPercentOwner2014-01-15Purchase512,500.0$8.0
NEW ENTERPRISE ASSOCIATES 13 LPTenPercentOwner2014-01-15Purchase512,500.0$8.0
NEA 13 GP, LtdTenPercentOwner2014-01-15Purchase512,500.0$8.0
NEA Partners 13, Limited PartnershipTenPercentOwner2014-01-15Purchase512,500.0$8.0
Viswanathan RaviTenPercentOwner2014-01-15Purchase512,500.0$8.0
NEW ENTERPRISE ASSOCIATES 10 L PTenPercentOwner2014-01-15Purchase487,500.0$8.0
NEA PARTNERS 10 L PTenPercentOwner2014-01-15Purchase487,500.0$8.0